Cosmo Pharmaceuticals N.V. (COPN.SW)

Home
COPN.SW
Financials

66.8 (CHF) • At close November 4, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) CHF.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Revenue Numbers are in millions	92.78	102.089	65.074	60.949	62.495	65.617	67.242	67.664	60.607	79.593	56.368	59.537	33.509	32.05	26.685	34.173	21.9	15.158	15.506	11.03
Cost of Revenue Numbers are in millions	18.836	18.762	15.14	10.444	9.247	12.37	12.125	10.187	10.076	11.62	10.282	8.418	14.492	14.326	12.774	13.203	7.022	5.497	5.74	4.154
Gross Profit Numbers are in millions	73.944	83.327	49.934	50.505	53.248	53.247	55.117	57.477	50.531	67.973	46.086	51.119	19.017	17.724	13.911	20.97	14.878	9.661	9.766	6.876
Gross Profit Ratio Numbers are in millions	0.797	0.816	0.767	0.829	0.852	0.811	0.82	0.849	0.834	0.854	0.818	0.859	0.568	0.553	0.521	0.614	0.679	0.637	0.63	0.623
Reseach & Development Expenses Numbers are in millions	18.811	15.525	11.357	13.597	15.694	10.523	9.096	8.257	28.686	24.82	23.205	10.916	5.173	6.779	4.454	4.287	0	0	0	0
General & Administrative Expenses Numbers are in millions	4.801	3.131	2.469	4.146	4.614	8.34	6.387	3.661	2.233	2.251	2.034	1.47	5.692	6.218	5.329	5.546	6.629	4.664	2.481	2.297
Selling & Marketing Expenses Numbers are in millions	0.602	0.419	0.339	0.337	5.241	9.901	9.477	0.14	0.047	1.53	0.03	0.081	0	0	0	0	0	0.543	0.247	0.068
SG&A Numbers are in millions	5.403	3.55	2.808	4.483	9.855	18.241	15.864	3.801	2.28	3.781	2.064	1.551	5.692	6.218	5.329	5.546	6.629	5.207	2.728	2.365
Other Expenses Numbers are in millions	61.372	51.72	36.025	39.117	55.7	51.627	0	0	0	0	0	0.006	0	0	0	0	0	0.248	0.308	0.49
Operating Expenses Numbers are in millions	66.775	55.27	38.833	43.6	65.555	69.868	64.721	32.08	55.965	45.759	33.148	24.67	10.109	12.922	9.468	9.786	14.657	11.473	8.476	7.643
Operating Income Numbers are in millions	6.146	28.057	33.114	2.056	-12.307	-16.621	-15.496	21.005	250.303	22.214	12.938	26.455	9.94	5.413	5.733	12.553	0.221	-1.59	1.609	-0.591
Operating Income Ratio Numbers are in millions	0.066	0.275	0.509	0.034	-0.197	-0.253	-0.23	0.31	4.13	0.279	0.23	0.444	0.297	0.169	0.215	0.367	0.01	-0.105	0.104	-0.054
Total Other Income Expenses Net Numbers are in millions	-4.615	-3.584	-9.111	-8.987	-8.997	-0.838	-16.936	6.486	3.987	86.637	58.733	0.433	-0.847	-0.954	-0.416	-0.94	-0.068	2.393	-0.298	-0.629
Income Before Tax Numbers are in millions	1.532	24.473	24.003	-6.931	-21.304	-17.459	-32.432	27.491	254.29	108.851	71.671	26.888	9.093	4.459	5.317	11.613	0.153	0.803	1.311	-1.22
Income Before Tax Ratio Numbers are in millions	0.017	0.24	0.369	-0.114	-0.341	-0.266	-0.482	0.406	4.196	1.368	1.271	0.452	0.271	0.139	0.199	0.34	0.007	0.053	0.085	-0.111
Income Tax Expense Numbers are in millions	6.264	6.968	2.33	0.97	3.19	0.598	0.015	8.151	6.099	35.529	2.938	7.564	1.487	0.852	1.267	2.212	0.037	0.94	0.473	0.977
Net Income Numbers are in millions	-4.932	17.225	21.672	-7.901	-24.494	-18.057	-32.447	19.34	248.192	73.321	68.733	19.323	7.606	3.607	4.05	9.401	0.116	-0.137	0.838	-2.197
Net Income Ratio Numbers are in millions	-0.053	0.169	0.333	-0.13	-0.392	-0.275	-0.483	0.286	4.095	0.921	1.219	0.325	0.227	0.113	0.152	0.275	0.005	-0.009	0.054	-0.199
EPS Numbers are in millions	-0.31	1.05	1.29	-0.55	-1.67	-1.2	-2.19	1.37	17.6	5.12	4.81	1.41	0.53	0.25	0.3	0.68	0.009	-0.016	0.33	-0.96
EPS Diluted Numbers are in millions	-0.31	1.05	1.28	-0.55	-1.67	-1.2	-2.19	1.17	17.05	5.03	4.8	1.4	0.53	0.24	0.27	0.68	0.009	-0.016	0.33	-0.96
EBITDA Numbers are in millions	24.017	47.504	40.483	8.091	-9.509	-10.749	-27.368	32.966	6.581	35.709	22.653	29.548	12.16	7.422	7.426	14.154	1.681	-0.098	2.511	0.202
EBITDA Ratio Numbers are in millions	0.259	0.465	0.622	0.133	-0.152	-0.164	-0.407	0.487	0.109	0.449	0.402	0.496	0.363	0.232	0.278	0.414	0.077	-0.006	0.162	0.018

Cosmo Pharmaceuticals N.V.

SIX:COPN.SW Add to watchlist

SIX:COPN.SW